Douglas Fambrough

Director, Solexa, Inc.

Companies

Oncorus, Inc.Board member Jun 24, 2022 to Jun 24, 2022¹
Dicerna Pharmaceuticals (United States)Board member Jan 29, 2014 to Dec 29, 2021²
Dicerna Pharmaceuticals (United States)Chief executive officer Jan 29, 2014 to Dec 29, 2021²
Dicerna Pharmaceuticals (United States)President Sep 1, 2020 to Aug 10, 2021³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 28, 2021Returned to company 231,431 shares at $38.25 of Dicerna Pharmaceuticals (United States)⁴
Dec 15, 2021Shares withheld for tax 5,348 shares at $38.05 of Dicerna Pharmaceuticals (United States)⁵
Dec 15, 2021Exercised options 13,750 shares of Dicerna Pharmaceuticals (United States)⁵
Dec 10, 2021Exercised options 146,195 shares at $3.42 of Dicerna Pharmaceuticals (United States)⁶
Dec 10, 2021Exercised options 33,670 shares at $2.97 of Dicerna Pharmaceuticals (United States)⁶

The numbers on this page point here. Each one links to the record it came from.